Appearance
Compact, frosty buds with purple highlights.
Grow Pharma · Indica-dominant
Grow Pharma T18 Northern Lights
Bred by Grow Pharma.
THC16–20% THCCultivationIndoor
Educational reference. Not medical advice. Medical cannabis is a prescription-only medicine in the UK — consult a specialist clinician.
History & Producer
Origin
Reliable Northern Lights expression.
Genetics
Lineage
Afghani × Thai
Indica 90%Sativa 10%
Cannabinoid & Production Profile
Specifications
- THC
- 16–20% THC
- CBD
- <1.0%
- Classification
- Indica-dominant
- Cultivation
- Indoor
- Irradiation
- Beta (e-beam)
Dominant Terpenes
Aromatic Compounds
- Myrcene0.85%Earthy · clove
- β-Caryophyllene0.42%Pepper · spice
- Linalool0.21%Lavender · floral
Sensory Profile
Appearance, Flavour & Aroma
Flavour
Sweet pine, earth.
Aroma
Pine, earth.
Reported Effects
Effect Profile
Aggregated from patient diaries and prescriber feedback. Intensity is relative within this strain's profile, not an absolute clinical measure.
Relaxed88%
Sleepy82%
Body Heaviness76%
Pain Relief78%
Euphoric58%
Appetite60%
Condition Recommendations
Discussed Indications
Chronic pain
Evidence · Emerging
Myrcene-dominant profile commonly prescribed for nocturnal musculoskeletal and neuropathic pain.
Strong fitInsomnia / sleep maintenance
Evidence · Emerging
Sedating terpene profile typically prescribed as an evening cultivar.
Strong fitTreatment-resistant anxiety
Evidence · Limited
Calming profile may help; high THC unsuitable for THC-naive patients.
Moderate fitDaytime productivity
Evidence · Anecdotal
Sedating profile is generally unsuitable for daytime cognitive demands or driving.
Caution
Not a substitute for a prescriber's assessment. Suitability depends on tolerance, comorbidities and concomitant medication.
More from Grow Pharma
